Winner Medical Co Ltd (300888) — Capital Reinvestment Ratio
Winner Medical Co Ltd (300888) has a Capital Reinvestment Ratio of 0.58x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥384.40 Million) in capital expenditures (CN¥221.37 Million). Check Winner Medical Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Winner Medical Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Winner Medical Co Ltd's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see Winner Medical Co Ltd (300888) cash flow conversion.
Annual Capital Reinvestment Ratio for Winner Medical Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Winner Medical Co Ltd from 2013 to 2025. See 300888 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | CN¥1.67 Billion | CN¥647.91 Million | ▼ -45.3% |
| 2024 | 0.71x | CN¥1.27 Billion | CN¥900.89 Million | ▲ +0.5% |
| 2023 | 0.71x | CN¥1.06 Billion | CN¥753.07 Million | ▲ +76.2% |
| 2022 | 0.40x | CN¥2.98 Billion | CN¥1.20 Billion | ▼ -52.9% |
| 2021 | 0.85x | CN¥871.69 Million | CN¥743.27 Million | ▲ +609.1% |
| 2020 | 0.12x | CN¥4.77 Billion | CN¥573.26 Million | ▼ -83.9% |
| 2019 | 0.75x | CN¥599.77 Million | CN¥446.90 Million | ▼ -45.4% |
| 2018 | 1.36x | CN¥467.86 Million | CN¥638.14 Million | ▼ -7.9% |
| 2017 | 1.48x | CN¥357.80 Million | CN¥530.04 Million | ▲ +131.6% |
| 2016 | 0.64x | CN¥450.14 Million | CN¥287.97 Million | ▼ -35.6% |
| 2015 | 0.99x | CN¥269.29 Million | CN¥267.31 Million | ▲ +46.5% |
| 2014 | 0.68x | CN¥203.96 Million | CN¥138.17 Million | ▼ -30.2% |
| 2013 | 0.97x | CN¥124.39 Million | CN¥120.69 Million | — |